Inventaire - your friends and communities are your best library

Methods for gene transfer to the central nervous system

published in: Advances in Genetics

date of publication: 2014-01-01

Cites articles 200

Too many entities requested (333). Only 200 are displayed.

Date

Title

Authors

2014-01-20

Herpes simplex virus-based nerve targeting gene therapy in pain management
2014-01-23

Central nervous system delivery of helper-dependent canine adenovirus corrects neuropathology and behavior in mucopolysaccharidosis type VII mice

Rosemary Thwaite, Miguel Chillon, Eric J Kremer, Assumpció Bosch
2013-12-20

Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer

Jean-Philippe Julien, Bridget Carragher, Ian Andrew Wilson, Dennis R. Burton, Andrew B Ward, Rogier W Sanders, John P. Moore, Albert Cupo, Natalia de Val, Per Johan Klasse
2013-12-20

Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer

Jean-Philippe Julien, Marc C. Deller, Ian Andrew Wilson, Dennis R. Burton, Andrew B Ward, Rogier W Sanders, John P. Moore, Robyn L Stanfield, Albert Cupo, Per Johan Klasse, Devin Sok
2013-09-18

Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis

Robert H Brown
2013-09-25

Lentiviral-mediated transfer of CDNF promotes nerve regeneration and functional recovery after sciatic nerve injury in adult rats
2013-09-03

Genomic cis-acting Sequences Improve Expression and Establishment of a Nonviral Vector

Claudia Hagedorn, Michael N Antoniou, Hans-Joachim Lipps
2013-08-01

Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome

Hélène Cheval, James C McGann, Adrian Peter Bird
2013-08-14

Integration-deficient lentiviral vectors expressing codon-optimized R338L human FIX restore normal hemostasis in Hemophilia B mice

Christof von Kalle, Manfred Schmidt
2013-07-01

Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy

Virginia Haurigot, Albert Ribera, Eduard Ayuso, Sonia Añor, Maria Molas, Sergio Muñoz, Sandra Motas, Fatima Bosch, Federico Mingozzi
2013-06-07

Myeloid/Microglial driven autologous hematopoietic stem cell gene therapy corrects a neuronopathic lysosomal disease
2013-01-01

Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier

Diego Dolcetta, Barbara Ruozi, Flavio Forni
2013-01-10

Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates
2012-11-13

Peptide derived from HIV-1 TAT protein destabilizes a monolayer of endothelial cells in an in vitro model of the blood-brain barrier and allows permeation of high molecular weight proteins
2012-09-25

Improved survival and reduced phenotypic severity following AAV9/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice

Kamal K E Gadalla, Mark E. S. Bailey
2012-09-19

The art of gene therapy for glioma: a review of the challenging road to the bedside
2012-10-11

Gene therapy for brain tumors: basic developments and clinical implementation

Maria G. Castro
2012-07-01

HIV-1 assembly, budding, and maturation

Hans-Georg Kräusslich
2012-06-27

Gene therapy and neurodevelopmental disorders
2012-06-02

Gene therapy for the treatment of chronic peripheral nervous system pain

Justus B. Cohen
2012-05-15

Sialic acid deposition impairs the utility of AAV9, but not peptide-modified AAVs for brain gene therapy in a mouse model of lysosomal storage disease
2012-01-01

Development of safe and effective nonviral gene therapy by eliminating CpG motifs from plasmid DNA vector
2012-03-28

Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates
2011-11-16

The Trojan Horse Liposome Technology for Nonviral Gene Transfer across the Blood-Brain Barrier

William M Pardridge, Ruben J Boado
2011-11-08

Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector

Mavis Agbandje-McKenna
2011-10-07

Viral vectors for gene delivery to the central nervous system
2011-08-02

Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders

Brian D. Coley, Arthur Burghes
2011-05-24

Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system
2011-06-28

Unique characteristics of AAV1, 2, and 5 viral entry, intracellular trafficking, and nuclear import define transduction efficiency in HeLa cells

Ziying Yan, John F Engelhardt
2011-04-12

Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates
2011-06-01

Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors

Mark J. Zylka
2011-03-08

Correction of neurological disease of mucopolysaccharidosis IIIB in adult mice by rAAV9 trans-blood-brain barrier gene delivery

Article - wd:Q35902332

Welcome to Inventaire

the library of your friends and communities

learn more